Effect of omalizumab in health care workers with occupational latex allergy.
Leynadier
Francisque
F
Doudou
Ouafia
O
Gaouar
Hafida
H
Le Gros
Vincent
V
Bourdeix
Isabelle
I
Guyomarch-Cocco
Laurence
L
Trunet
Patrick
P
D000328:Adult; D000485:Allergens / Q000009:adverse effects; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004311:Double-Blind Method; D005260:Female; D005932:Gloves, Surgical; D006282:Health Personnel; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007840:Latex / Q000009:adverse effects; D020315:Latex Hypersensitivity / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D009784:Occupational Diseases / Q000188:drug therapy* / Q000209:etiology; D016273:Occupational Exposure; D000069444:Omalizumab; D012882:Skin Tests; D016896:Treatment Outcome
D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007840:Latex; D000069444:Omalizumab; D007073:Immunoglobulin E